标题
Neoadjuvant therapy of cetuximab combined with chemoradiotherapy in rectal cancer
作者
关键词
-
出版物
MEDICINE
Volume 100, Issue 7, Pages e24649
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-02-27
DOI
10.1097/md.0000000000024649
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of Oxaliplatin/5-Fluorouracil/Capecitabine-Cetuximab Combination Therapy and Its Effects on K-Ras Mutations in Advanced Colorectal Cancer
- (2020) Li Wei et al. MEDICAL SCIENCE MONITOR
- Total Neoadjuvant Therapy in Rectal Cancer
- (2019) Fausto Petrelli et al. ANNALS OF SURGERY
- Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
- (2018) Cynthia Gail Leichman et al. Clinical Colorectal Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision
- (2017) Soo-Y Sung et al. ANNALS OF SURGERY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
- (2016) Sebastian Stintzing et al. LANCET ONCOLOGY
- Role of First-Line Anti–Epidermal Growth Factor Receptor Therapy Compared With Anti–Vascular Endothelial Growth Factor Therapy in Advanced Colorectal Cancer: A Meta-Analysis of Randomized Clinical Trials
- (2015) Muhammad A. Khattak et al. Clinical Colorectal Cancer
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data
- (2015) Lesley A. Stewart et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
- (2014) M. J. Sorich et al. ANNALS OF ONCOLOGY
- Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial
- (2014) Deborah Schrag et al. JOURNAL OF CLINICAL ONCOLOGY
- Acquired resistance to EGFR-targeted therapies in colorectal cancer
- (2014) Beth O. Van Emburgh et al. Molecular Oncology
- Preoperative Chemoradiation Therapy With Capecitabine/Oxaliplatin and Cetuximab in Rectal Cancer: Long-Term Results of a Prospective Phase 1/2 Study
- (2013) Emmanouil Fokas et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
- (2012) Pei-Long Sun et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)
- (2012) Alice Dewdney et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial
- (2012) Vaneja Velenik et al. Radiology and Oncology
- Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer
- (2011) P. P. Grimminger et al. CLINICAL CANCER RESEARCH
- Activating KRAS Mutations and Overexpression of Epidermal Growth Factor Receptor as Independent Predictors in Metastatic Colorectal Cancer Patients Treated With Cetuximab
- (2010) Li-Chen Yen et al. ANNALS OF SURGERY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Cetuximab in Combination With Capecitabine, Irinotecan, and Radiotherapy for Patients With Locally Advanced Rectal Cancer: Results of a Phase II MARGIT Trial
- (2009) Karoline Horisberger et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer
- (2009) Catherine Liebig et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- EGFR, HER-2 and COX-2 levels in colorectal cancer
- (2008) A G Antonacopoulou et al. HISTOPATHOLOGY
- Phase I-II Trial of Cetuximab, Capecitabine, Oxaliplatin, and Radiotherapy as Preoperative Treatment in Rectal Cancer
- (2007) Claus Rödel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started